ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 110 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $437,847 | -56.3% | 65,546 | -35.0% | 0.00% | -75.0% |
Q1 2023 | $1,002,026 | +884.9% | 100,909 | +590.4% | 0.00% | – |
Q4 2022 | $101,734 | -26.3% | 14,617 | -43.6% | 0.00% | – |
Q3 2022 | $138,000 | +48.4% | 25,913 | +11.1% | 0.00% | – |
Q2 2022 | $93,000 | -71.4% | 23,316 | -68.1% | 0.00% | – |
Q1 2022 | $325,000 | +3.2% | 73,068 | -7.4% | 0.00% | – |
Q4 2021 | $315,000 | -55.9% | 78,868 | -3.0% | 0.00% | -100.0% |
Q3 2021 | $714,000 | -0.7% | 81,321 | +34.3% | 0.00% | 0.0% |
Q1 2021 | $719,000 | +301.7% | 60,553 | +150.6% | 0.00% | 0.0% |
Q3 2020 | $179,000 | +336.6% | 24,162 | +147.9% | 0.00% | – |
Q2 2020 | $41,000 | +127.8% | 9,747 | +37.2% | 0.00% | – |
Q1 2020 | $18,000 | -72.3% | 7,102 | -36.4% | 0.00% | – |
Q4 2019 | $65,000 | +97.0% | 11,175 | +78.4% | 0.00% | – |
Q3 2019 | $33,000 | -64.5% | 6,263 | -59.5% | 0.00% | -100.0% |
Q2 2019 | $93,000 | -62.7% | 15,463 | -43.9% | 0.00% | -66.7% |
Q1 2019 | $249,000 | +4050.0% | 27,555 | +5929.5% | 0.00% | – |
Q3 2018 | $6,000 | 0.0% | 457 | -34.7% | 0.00% | – |
Q2 2018 | $6,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |